Joseph G. Oliveto Net Worth

The estimated Net Worth of Joseph Oliveto is at least $1.05 Million dollars as of 21 December 2019. Mr Oliveto owns over 7,400 units of Milestone Pharmaceuticals Inc stock worth over $406,805 and over the last 5 years he sold MIST stock worth over $0. In addition, he makes $646,383 as CEO and Pres & Director at Milestone Pharmaceuticals Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Oliveto MIST stock SEC Form 4 insiders trading

Mr has made over 1 trades of the Milestone Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 7,400 units of MIST stock worth $11,396 on 21 December 2019.

The largest trade he's ever made was exercising 7,400 units of Milestone Pharmaceuticals Inc stock on 21 December 2019 worth over $11,396. On average, Mr trades about 1,480 units every 0 days since 2019. As of 21 December 2019 he still owns at least 280,555 units of Milestone Pharmaceuticals Inc stock.

You can see the complete history of Mr Oliveto stock trades at the bottom of the page.

Mr. Joseph G. Oliveto biography

Joseph G. Oliveto is the CEO, Pres & Director at Milestone Pharmaceuticals Inc.

What is the salary of Mr Oliveto?

As the CEO and Pres & Director of Milestone Pharmaceuticals Inc, the total compensation of Mr Oliveto at Milestone Pharmaceuticals Inc is $646,383. There are no executives at Milestone Pharmaceuticals Inc getting paid more.

How old is Mr Oliveto?

Mr Oliveto is 53, he's been the CEO and Pres & Director of Milestone Pharmaceuticals Inc since . There are 4 older and 1 younger executives at Milestone Pharmaceuticals Inc. The oldest executive at Milestone Pharmaceuticals Inc is Dr. Philip T. Sager FACC, FAHA, FHRS, M.D., 65, who is the Chief Medical Advisor & Member of the Scientific Advisory Board.

What's Mr Oliveto's mailing address?

Joseph's mailing address filed with the SEC is C/O MILESTONE PHARMACEUTICALS INC., 1111 DR. FREDERIK-PHILIPS BLVD, STE 420, MONTR?AL, A8, H4M 2X6.

Insiders trading at Milestone Pharmaceuticals Inc

Over the last 6 years, insiders at Milestone Pharmaceuticals Inc have traded over $8,160,062 worth of Milestone Pharmaceuticals Inc stock and bought 3,714,592 units worth $46,347,389 . The most active insiders traders include Holdings A/S Novo, Investments, Lpwong Roderic..., and Joseph C Papa. On average, Milestone Pharmaceuticals Inc executives and independent directors trade stock every 57 days with the average trade being worth of $438,690. The most recent stock trade was executed by David Bharucha on 1 December 2022, trading 10,000 units of MIST stock currently worth $47,400.

What does Milestone Pharmaceuticals Inc do?

milestone pharmaceuticals is a biotechnology company located in 6100 royalmount ave, montreal, qc, canada.

Complete history of Mr Oliveto stock trades at Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc executives and stock owners

Milestone Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

• Joseph G. Oliveto,
  CEO, Pres & Director
• Amit Hasija,
  CFO & Exec. VP of Corp. Devel.
• Dr. Francis Plat,
  Chief Medical Officer
• Lorenz Muller,
  Chief Commercial Officer
• Dr. Philip T. Sager FACC, FAHA, FHRS, M.D.,
  Chief Medical Advisor & Member of the Scientific Advisory Board
• Jeff Nelson,
  Chief Operating Officer
• Dr. Philippe Douville,
  Founder, Strategic Advisor & Member of Scientific Advisory Board
• Richard C Pasternak,
  Director
• Debra K. Liebert,
  Director
• Paul F Truex,
  Director
• Joseph C Papa,
  
• Amit Hasija,
  CFO & EVP of Corp. Development
• Seth H. Z. Fischer,
  
• Timothy Maness,
  Chief Accounting Officer
• Philippe Douville,
  Chief Scientific Officer
• De Solidarite Des Travaille...,
  10% owner
• Holdings A/S Novo,
  10% owner
• Investments, Lpwong Roderic...,
  
• Capital Inc. Bdc,
  10% owner
• Francis Plat,
  Chief Medical Officer
• Joseph Oliveto,
  President and CEO
• Lorenz Muller,
  Chief Commercial Officer
• Paul R Edick,
  Director
• Michael John Tomsicek,
  
• Stuart Duty,
  
• David Bharucha,
  Chief Medical Officer
• Jeffrey Edward Nelson,
  Chief Operating Officer
• Lisa M. Giles,
  
• Robert James Wills,